Cumberland Pharmaceuticals (CPIX) Net Margin (2010 - 2026)
Cumberland Pharmaceuticals (CPIX) posted Net Margin of 34.4% for Q1 2026, down 232.42% sequentially from 10.35% in Q4 2025, and down 4505.0% YoY from 0.78% in Q1 2025.
Cumberland Pharmaceuticals (CPIX) Net Margin (2010 - 2026) Analysis & Trends
Cumberland Pharmaceuticals has reported Net Margin for 16 years, with the latest figure at 34.4% in Q1 2026.
- Quarterly Net Margin fell 4505.0% year-over-year to 34.4% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 17.26% (down 925.0% YoY) and the FY2025 annual result came in at 6.4%, up 1061.0% from the prior year.
- Net Margin slipped to 34.4% in Q1 2026 per CPIX's latest filing, from 10.35% in the prior quarter.
- Over five years, Net Margin peaked at 10.66% in Q1 2025 and troughed at 67.38% in Q4 2023.
- A 4-year average of 15.48% and a median of 11.2% in 2024 frame the typical range for Net Margin.
- The sharpest annual moves came in 2024 and 2026: Net Margin soared 4916 bps in 2024, then tumbled 4505 bps in 2026.
- Over 4 years, Net Margin stood at 67.38% in 2023, then surged by 73 bps to 18.22% in 2024, then jumped by 43 bps to 10.35% in 2025, then plunged by 232 bps to 34.4% in 2026.
- According to Business Quant data, Net Margin over the past three periods registered 34.4%, 10.35%, and 23.5% for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.91 Bn | 42.95 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.07 Bn | 39.42 Bn | 2.15 Bn | -13.91% |
| 3 | Zoetis | 31.54 Bn | 29.86 Bn | 1.05 Bn | 35.09% |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | 9.28% |
| 5 | United Therapeutics | 22.19 Bn | 19.53 Bn | 683.80 Mn | 42.51% |
| 6 | Viatris | 18.68 Bn | 17.79 Bn | 1.46 Bn | -3.16% |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn | 15.06% |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 3.95% |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.96 Bn | - | - |
| 10 | Cumberland Pharmaceuticals | 117.68 Mn | 113.82 Mn | - | -2,567.87% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -703.04% |
| Mar 31, 2026 | -34.40% |
| Dec 31, 2025 | -10.35% |
| Sep 30, 2025 | -23.50% |
| Jun 30, 2025 | -6.78% |
| Mar 31, 2025 | 10.66% |
| Dec 31, 2024 | -18.22% |
| Sep 30, 2024 | -16.92% |
| Jun 30, 2024 | -11.20% |
| Mar 31, 2024 | -22.39% |
| Dec 31, 2023 | -67.38% |
| Sep 30, 2023 | -10.54% |
| Jun 30, 2023 | 7.92% |
| Mar 31, 2023 | 1.87% |
| Dec 31, 2021 | 6.05% |
| Sep 30, 2021 | 6.15% |
| Jun 30, 2021 | 5.51% |
| Mar 31, 2021 | 4.70% |
| Dec 31, 2020 | 8.50% |
| Sep 30, 2020 | 8.41% |